Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and therapy, 2015 - Taylor & Francis
Background Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …
被引用次数：36 相关文章
[PDF] psu.edu

[PDF][PDF] Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase iii randomized controlled trials

J Wang - OncoTargets and Therapy, 2015 - Citeseer
Background: Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and Therapy, 2015 - search.proquest.com
Background: Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …
[PDF] scienceopen.com

[PDF][PDF] Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase iii randomized controlled trials

J Wang - OncoTargets and Therapy, 2015 - scienceopen.com
Background: Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and Therapy, 2015 - go.gale.com
Background: Several clinical trials have performed risk-benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials.

X He, J Wang, Y Li - OncoTargets & Therapy, 2015 - search.ebscohost.com
Background: Several clinical trials have performed risk-benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …
[HTML] nih.gov

[HTML][HTML] Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and therapy, 2015 - ncbi.nlm.nih.gov
Background Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and therapy, 2015 - pubmed.ncbi.nlm.nih.gov
Background Several clinical trials have performed risk-benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

X He, J Wang, Y Li - OncoTargets and Therapy, 2015 - dovepress.com
Background: Several clinical trials have performed risk–benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials.

X He, J Wang, Y Li - Oncotargets and Therapy, 2015 - europepmc.org
Background Several clinical trials have performed risk-benefit analyses comparing
docetaxel and pemetrexed or docetaxel and vinca alkaloid, but the efficacy and safety …